INDUSTRY RELATIONS HUB LOGIN
PBM MEMBER PORTAL LOGIN
Search
START TYPING AND PRESS ENTER TO SEARCH

Federal Legislative Materials

Below, you’ll find materials related to specific bills. If you’re looking for information on a particular topic, click the button below to explore materials by subject.

Legislative Summaries

Drug Competition Enhancement Act (Mar. 2025)

View Document >>

Delinking Revenue from Unfair Gouging Act (The DRUG Act) (Mar. 2025)

View Document >>

Affordable Prescriptions for Patients Act (Mar. 2025)

View Document >>

Prescription Pricing for the People Act (Feb. 2025)

View Document >>

Ensuring Pathways to Innovative Cures (EPIC) Act (Feb. 2025)

View Document >>

Summary of EC Full Committee Markup (Dec. 2023)

View Document >>

Summary of Braun and Marshall Amendments

View Document >>

Senate Finance Markup (Nov. 2023)

View Document >>

Pharmacy Benefit Manager Transparency Act (2023)

View Document >>

Pharmacists Fight Back (2024)

View Document >>

Modernizing and Insuring PBM Accountability (MEPA) Summary (Sept. 2023)

View Document >>

Lower Costs More Transparency Summary (Sept. 2023)

View Document >>

Legislation Proposals Under Consideration (April 2023)

View Document >>

HELP Amendments (May 2023)

View Document >>

Health Care Price Transparency Act (2023)

View Document >>

Education and Workforce Committee Summaries

View Document >>

EC Markup (May 2023)

View Document >>

Continuing Resolution PBM Provisions Summary (Dec. 2024)

View Document >>

Continuing Resolution (Dec. 2024)

View Document >>

Build Back Better Act Short Summary (Aug. 2022)

View Document >>

Modernizing and Ensuring PBM Accountability Summary and Positioning

View Document >>

Lower Costs More Transparency Long Summary

View Document >>

Talking Points

The DRUG Act Would Not Lower Drug Prices But Would Increase Costs for Taxpayers, Employers and Patients

View Document >>

Transparency Measures That Promote Patient Care and Preserve Competition

View Document >>

Rebate Mandates Hurt Choice and Small Employers

View Document >>

Implications of the Drug Act

View Document >>

HR 9096 Would Increase Federal Health Care Program Costs

View Document >>

Enacting Delinking Would Ban Spread Pricing Talking Points

View Document >>

Comparison Documents

Comparison of PBM Reporting and Related Policies in the Commercial Market as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Transparency Tools Reporting as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Transparency in Coverage the Commercial Market as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on the Hidden Fee Disclosure Act as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on the Health DATA Act as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Pharmacy Performance Measures as Reported Out by the House and Senate

View Document >>

Comparison of PBM Policies on Pharmacy Payment Transparency as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on OIG Study on Part D Markups as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Medicaid Payment and Medicaid Spread Pricing as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Information at Pharmacy Counter as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Delinking in Medicare and Reporting as Reported Out by the House and Senate Committees

View Document >>

Comparison of PBM Policies on Common Ownership as Reported Out by the House and Senate Committees

View Document >>
Back to Member Area
Resources by Topic